Semiletova NV - Search Results

1

Soluble donor-like MHC class I proteins induce CD4(+)CD25(+)CD8(-)FoxP3(+) cells with potential to ameliorate graft chronic injury.

Andakyan A, Burruss S, Hong LS, Shen XD, Romanov S, Gao F, Feldman DM, Fishbein MC, Semiletova NV. Andakyan A, et al. Among authors: semiletova nv. Transpl Immunol. 2011 May;24(4):203-9. doi: 10.1016/j.trim.2011.01.002. Epub 2011 Jan 18. Transpl Immunol. 2011. PMID: 21251981

2

Class I MHC allochimeric presentation of composite immunogenic and self epitopes induces tolerance to genetically diverse rat strains.

Semiletova NV, Shen XD, Feldman DM, Gao F, Mhoyan A, Liu D, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM. Semiletova NV, et al. Cell Immunol. 2007 Jul;248(1):48-58. doi: 10.1016/j.cellimm.2007.04.008. Epub 2007 Oct 23. Cell Immunol. 2007. PMID: 17936255 Free PMC article.

3

Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells.

Semiletova NV, Shen XD, Baibakov B, Andakyan A. Semiletova NV, et al. J Heart Lung Transplant. 2010 Mar;29(3):335-41. doi: 10.1016/j.healun.2009.08.003. Epub 2010 Jan 15. J Heart Lung Transplant. 2010. PMID: 20080050

4

Inhibition of chronic rejection by antibody induced vascular accommodation in fully allogeneic heart allografts.

Semiletova NV, Shen XD, Baibakov B, Feldman DM, Mukherjee K, Frank JM, Stepkowski SM, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM. Semiletova NV, et al. Transplantation. 2005 Dec 15;80(11):1535-40. doi: 10.1097/01.tp.0000188952.10692.18. Transplantation. 2005. PMID: 16371921

5

Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection.

Semiletova NV, Shen XD, Slomowitz SJ, Baibakov B, Feldman DM, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM. Semiletova NV, et al. Transplant Proc. 2005 Jan-Feb;37(1):35-6. doi: 10.1016/j.transproceed.2004.12.061. Transplant Proc. 2005. PMID: 15808538

6

Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.

Semiletova NV, Shen XD, Feldman DM, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM. Semiletova NV, et al. Transplant Proc. 2005 May;37(4):1937-9. doi: 10.1016/j.transproceed.2005.02.114. Transplant Proc. 2005. PMID: 15919510

7

Effect of protein C gene mutation on coagulation and inflammation in hemorrhagic shock.

Burruss S, Andakyan A, Romanov S, Semiletova N, Cryer H. Burruss S, et al. J Surg Res. 2012 Jun 1;175(1):18-23. doi: 10.1016/j.jss.2011.06.055. Epub 2011 Jul 23. J Surg Res. 2012. PMID: 21962741

8

Regulatory T cells induced by allochimeric major histocompatability class I therapy inhibit allograft apoptosis.

Semiletova N, Shen XD, Gao F, Slomowitz SJ, Jiao Q, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM. Semiletova N, et al. Transplant Proc. 2002 Aug;34(5):1402. doi: 10.1016/s0041-1345(02)02904-4. Transplant Proc. 2002. PMID: 12176415 No abstract available.

9

Identification of early tolerance regulator genes induced by allochimeric therapy using microarray-based genomewide scan.

Liu D, Shen XD, Fang Z, Gao F, Semiletova N, Cao MJ, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM. Liu D, et al. Transplant Proc. 2005 May;37(4):1942-3. doi: 10.1016/j.transproceed.2005.03.147. Transplant Proc. 2005. PMID: 15919512

10

Early and long-term effects of chronic low-dose radiation and coenzyme Q diet on the proliferation of rat spleen T cells.

Novoselova EG, Semiletova NV, Makar VR, Gordon RYa. Novoselova EG, et al. Among authors: semiletova nv. Indian J Biochem Biophys. 1998 Apr;35(2):103-7. Indian J Biochem Biophys. 1998. PMID: 9753869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters